Shanghai Pharmaceuticals Holding Co., Ltd (HKG: 2607)

Shanghai Pharmaceuticals Holding Revenue

Shanghai Pharmaceuticals Holding had revenue of 70.22B CNY in the quarter ending September 30, 2024, with 8.16% growth. This brings the company's revenue in the last twelve months to 272.42B, up 6.88% year-over-year. In the year 2023, Shanghai Pharmaceuticals Holding had annual revenue of 260.30B with 12.21% growth.

• Revenue (ttm): 272.42B CNY
• Revenue Growth: +6.88%
• P/S Ratio: n/a
• Revenue / Employee: 5.66M CNY
• Employees: 48,164
• Market Cap: 76.58B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	260.30B	28.31B	12.21%
Dec 31, 2022	231.98B	16.16B	7.49%
Dec 31, 2021	215.82B	23.92B	12.46%
Dec 31, 2020	191.91B	5.34B	2.86%
Dec 31, 2019	186.57B	27.48B	17.27%